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Sage (Salvia ofﬁcinalis L.) is used as an herbal medicinal product, with the most typical
form of application as infusion with boiling water (sage tea). The well-established tradi-
tional uses include symptomatic treatment of mild dyspeptic complaints, the treatment of
inﬂammations in the mouth and the throat, and relief of excessive sweating and relief of
minor skin inﬂammations. In this study, sage teas prepared from commercially available
products were chemically analyzed for polyphenolic content using liquid chromatography,
for antioxidant potential using the oxygen radical absorbance capacity method, and for
the Folin–Ciocalteu (FC) index. The sage teas showed a high variation for all parameters
studied (up to 20-fold differences for rosmarinic acid). Univariate and multivariate analy-
ses showed that the antioxidant potential, which varied between 0.4 and 1.8mmol trolox
equivalents/100mL, was highly dependent on rosmarinic acid and its derivatives. The FC
index also showed a high correlation to these polyphenols, and could therefore be used
as a screening parameter for sage tea quality.The considerable differences in polyphenolic
composition and antioxidant capacity between the brands lead to a demand for quality
standardization, especially if these sage teas are to be used for therapeutic purposes. Fur-
ther research also appears to be necessary to characterize the dose–beneﬁt relationship,
as sage may also contain a constituent (thujone) with potentially adverse effects.
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INTRODUCTION
Sage (Salvia ofﬁcinalis L.) has been an important herbal medicinal
product since very early times and is still in wide use today. An
infusion of dried sage leaves with boiling water (sage tea) is the
most typical form of preparation (Dweck, 2000). Although well-
established traditional uses of sage include symptomatic treatment
of mild dyspeptic complaints, the treatment of inﬂammations in
the mouth and the throat, and relief of excessive sweating and
minor skin inﬂammations, only a few clinical trials thus far have
been conducted to corroborate these uses.
The European Medicines Agency (EMA) reported a number of
unpublished studies conﬁrming the perspiration–inhibiting and
antihidrotic effects of sage (European Medicines Agency, 2009).
The efﬁcacy of sage for the treatment of hot ﬂushes during
menopause was proven by a multicentre open clinical trial (Bom-
mer et al., 2009). A statistically signiﬁcant effect of symptomatic
relief in patients with acute pharyngitis was detected (Hubbert
et al., 2006). In addition, sage combined with Echinacea was efﬁ-
cacious in the treatment of acute sore throats (Schapowal et al.,
2009). A double-blind, randomized, and placebo-controlled trial
also indicated that sage may improve the symptoms of Alzheimer’s
disease (Akhondzadeh et al., 2003). Sage tea was effective in the
improvement of lipid proﬁle, antioxidant defenses, and lympho-
cyte Hsp70 protein expression in human volunteers (Sá et al.,
2009).
Animal experiments and in vitro studies have substantiated that
Salvia ofﬁcinalis extracts may signiﬁcantly decrease serum glu-
cose in diabetic rats (Eidi et al., 2005) and positively affect the
antioxidant status of the liver (Lima et al., 2005). Sage may also
inhibit pro-oxidant-induced lipid peroxidation in rat brain and
liver homogenates (Oboh and Henle, 2009). Further in vitro mod-
els showed Salvia as possibly being antiangiogenic, antimutagenic,
antidiabetic, and gastroprotective (Lima et al., 2006; Mayer et al.,
2009; Patenkovic et al., 2009; Keshavarz et al., 2010). Although the
underlying mechanisms of action are unknown, polyphenols such
as carnosol, carnosic acid, rosmanol, apigenin, hispidulin, caffeic
acid, and ursolic acid have been discussed as active compounds
for these pharmacological effects (Imanshahidi and Hosseinzadeh,
2006). An excellent review on sage polyphenols was provided by
Lu and Foo (2002).
We have previously discussed the potentially adverse effects of
sage attributed to the presence of the neurotoxic monoterpene
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compound thujone; however, this compound was found to be
below thresholds of toxicity at normal levels of use (Lachenmeier
and Uebelacker, 2010; Walch et al., 2011). In this contribution, we
have focused on the beneﬁcial effects of sage due to antioxidant
capacity and polyphenol content, as analyzed by a recently devel-
oped methodology (Zimmermann et al., 2011). It is interesting
that neither the European Pharmacopoeia (2008) monograph nor
the ISO (1995) standard 11165 on sage demand a standardization
regarding the content of polyphenols and antioxidant capacity,
and a general lack of knowledge on these constituents exists. Ear-
lier studies provided information of only single samples of herbal
sage tea (Aoshima et al., 2007; Hossain et al., 2011). By analyzing
different sage tea brands from the German market, we will try
to determine whether considerable differences in tea brands exist
and if these differences are related to product quality. We will also
investigate the contribution of polyphenolic constituents to the
antioxidant capacity measured by the oxygen radical absorbance
capacity (ORAC) method.
MATERIALS AND METHODS
SAMPLE PREPARATION
Infusions were prepared in a 250-mL Erlenmeyer ﬂask by adding
150 mL boiling water to one tea bag (containing 1.5 g) or 1.5 g
of herbal sage material in the case of loose tea. The infusion was
allowed to steep for 15 min and was shaken every 5 min. All sam-
ples were prepared as delivered, e.g., whole leafs were not crushed.
One milliliter of the infusion was ﬁltered through a disposable
polyester ﬁlter (Chromaﬁl PET-20/25, Macherey-Nagel, Düren,
Germany) with 0.20μm pore size and injected into the HPLC
system within 20 min or diluted immediately for the ORAC and
Folin–Ciocalteu (FC) analyses.
APPARATUS AND SOFTWARE FOR LC–MS/MS MEASUREMENT
Method development, compound identiﬁcation, quantiﬁcation,
and validation was previously described in detail (Zimmermann
et al., 2011). In short, anAcquity UPLC system byWaters (Milford,
MA, USA) consisting of a binary pump (BSM), an autosampler
(SM; cooled to 10˚C; injected volume: 3μL), a column oven (CM)
set at 40˚C, a diode array detector (PDA) scanning from 190 to
400 nm (wavelengths for quantiﬁcation: 273, 320, and 360 nm),
and a triple quadrupole mass spectrometer (Acquity TQD) with
electrospray interface operating in negative mode was used. An
Acquity BEH Shield RP18 column (150 mm× 2.1 mm, 1.7μm;
Waters) was used for separation with water (A) and acetonitrile
(B) as eluents, both acidiﬁed with 0.1% (v/v) formic acid at a ﬂow
rate of 0.4 mL/min with gradient elution: 0 min: 4% A, 14 min:
27% A, 28 min: 59.7% A, 28.2 min: 100% A, 30.5 min: 100% A,
31 min: 4% A, 34 min: 4% A.
The mass spectrometer was tuned using a solution of pure ros-
marinic acid and luteolin-7-O-glucuronide. The resulting para-
meters for themeasurementswere a compromise between theopti-
mal parameters for these compounds: capillary voltage −2.0 kV,
cone voltage 30V, extractor voltage 1.0V, RF voltage 0.20V, source
temperature 150˚C, desolvation temperature 400˚C, cone gas
(nitrogen) ﬂow 50 L/h, desolvation gas (nitrogen) ﬂow 800 L/h.
The collision gas (argon) ﬂow in tandem mass spectrometry mode
was 0.3 mL/min. The whole system was controlled by MassLynx
4.1 software. Averages from analysis in duplicate are reported. The
relative SD was 5.0% on average. For full validation results see
Zimmermann et al. (2011).
DETERMINATION OF ANTIOXIDANT CAPACITY AND FC INDEX
TheORACmethodwas used to determine the antioxidant capacity
of the tea samples (Prior et al., 2003). Reagents: 2,2′-azobis-
(2-amidino-propane)-dihydrochloride (AAPH; 240 mM), 6-
hydroxy-2,5,7,8-tetra-methylchroman-2-carboxylic acid (trolox;
100–6.25μM), ﬂuorescein sodium salt (10 nM). All chemicals
were obtained by Aldrich/Sigma-Aldrich (Taufkirchen, Germany)
and dissolved in phosphate buffer pH 7.4, 10 mM.
The ﬂuorescence was measured by a 96-well plate reader (FLU-
Ostar Optima, BMG Labtech, Offenburg, Germany). Every solu-
tionwas pipetted in duplicate: 25 μLof trolox dilution as reference,
25μL of sample dilution, and 25μL of phosphate buffer as blank.
After an incubation period of 30 min at 37˚C, three ﬂuorescence
measurements (excitation 485 nm, emission 520 nm) were taken
every 90 s to determine the background. After that, AAPH was
added, and ﬂuorescence was measured every 90 s for 60 min.
Data were evaluated using the MARS software, version 2.0 (BMG
Labtech). Averages from analysis in duplicate are reported. The
relative SD was 4.9% on average.
The FC test was used to further characterize the samples. The
FC index was determined according to the reference procedure for
wine analysis (European Commission, 1990) using a commercial
FC reagent (Merck, Darmstadt, Germany, No. 1.09001.0100).
200μL of sage tea (from the infusion described above), 10 mL of
distilled water, 1 mL of FC reagent, and 4 mL of sodium carbonate
solution (2 g/L)were placed into a calibrated 20-mLﬂask and ﬁlled
up to the mark with distilled water. The absorbance was measured
at 750 nm after 30 min. The result of the test was expressed in the
form of an index obtained by multiplying the absorbance by 20.
Averages from analysis in triplicate are reported. The relative SD
was 3.5% on average.
DATA ANALYSIS
All data were evaluated using Origin V7.5 (Originlab, Northamp-
ton, MA, USA). Statistical signiﬁcance was assumed at below
the 0.05 probability level. Pearson’s test was used to evalu-
ate the signiﬁcance of linearity of calibration curves as well
as of the correlation between different parameters. For explo-
rative multivariate data analysis aiming to visualize the data
set, the software Unscrambler X version 10.0.1 (Camo Soft-
ware AS, Oslo, Norway) was used. The multivariate evalua-
tion was conducted using principal component analysis (PCA)
based on a data matrix containing all substances from LC–
MS as well as ORAC and FC index values. Standardization
was used prior to PCA to give all variables the same vari-
ance.
RESULTS
Atﬁrst sight, the commercial teas appeared todiffer notably in their
polyphenolic proﬁles as well as ORAC and FC values (Table 1). In
the polyphenols analysis, the dominating compounds were either
rosmarinic acid or luteolin-7-O-glucuronide. The concentrations
ranged from 12.2 to 296 mg/L (rosmarinic acid) and from 37.9 to
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FIGURE 1 | Explorative data analysis of the analytical results of 16
commercial sage tea infusions.The principal component analysis (PCA)
plots show the scores (sample numbers 1–16; upper panel) and loadings
(names of analytes; lower panel).
166 mg/L (luteolin-7-O-glucuronide). Amongst the triterpenes,
carnosic acid had the highest concentrations, ranging from 9.1 to
32.9 mg/L. In all but two samples the sum of the concentrations
of the caffeic acid derivatives was higher than the sum of the con-
centrations of the triterpenes. The ORAC values ranged between
0.4 and 1.8 mmol Trolox Equivalents (TE)/100 mL, whereas the
FC index varied between 6.7 and 15.2. In all cases, the differences
between the tea brands cannot be explained by the uncertainty of
the analytical methods.
The results of the explorative data analysis is shown in Figure 1.
The PCA scores conﬁrm that a considerable difference exists
in the composition of the commercial sage tea samples. Sam-
ples 6 and 7 were different from the rest of the samples, espe-
cially regarding to their high antioxidative potential. Further-
more, both samples had a high content of polyphenols and
high levels of rosmarinic acid and its derivatives. Sample 10 was
peculiar not only for higher rosmarinic acid and ORAC lev-
els but especially for its high levels of ﬂavone glycosides, which
made it different from all other samples. The PCA loadings
plot suggests a correlation between ORAC, FC index, and ros-
marinic acid and its derivatives. This ﬁnding is conﬁrmed by
univariate linear correlation analysis (FC index and rosmarinic
acid, R = 0.86 p< 0.0001; ORAC and rosmarinic acid, R = 0.68
p = 0.00355).
DISCUSSION
Our analytical results showed a higher variability of the com-
position of sage teas than what we actually had expected. For
example, the content of rosmarinic acid varied by more than a
factor of 20 between the lowest and highest brands of sage tea.
This shows that it is important to analyze a comprehensive num-
ber of samples rather than single samples as it has been done
in previous studies (Aoshima et al., 2007; Hossain et al., 2011).
The difference in polyphenols content is also evidenced by the
corresponding antioxidative potential, which varied from 0.4 to
1.8 mmol TE/100 mL. The information on the packages did not
provide details about the plant origins or the exact composition,
making it difﬁcult for us to explain the (possible) factors leading
to these differences. The brands with the highest ORAC and FC
index (samples 6 and 7) were labeled to be hand-collected shoot
apex material from organic farming (sample 6) or sage tea selected
from shoot apex material (sample 7). This could explain the dif-
ference between these two samples and the other tea samples,
which appear mainly to be composed of leaf material. Previous
research on FC index, thujone and camphor (Walch et al., 2011)
has reported results from several batches of a single manufacturer,
which were very consistent. For example, the FC index for ﬁve
different batches of shoot apex material (corresponding to sam-
ple 6 in this study) was 14.9± 0.3. Similar to the results in this
study for polyphenols, ORAC, and FC index, the variations for
thujone and camphor were signiﬁcantly higher between manufac-
turers than within a single brand. This indirect evidence points
to sage variety and chemotype, cultivation conditions, climate, or
processing conditions (especially during drying) as explanations
for the differences rather than pure inter-batch variations.
It is interesting to note that sage tea not only is available as
an herbal medicinal product but is also sold as a food product in
many supermarkets, as it may simply be consumed as a “pleasant
drink” for culinary purposes (Dweck, 2000; British Herbal Com-
pendium, 2006). There was no distinct difference between the teas
marketed as medicine (samples 1–13) and those marketed as food
(samples 14–16). In contrast, the brands with the lowest ORAC
(samples 4, 5, and 8) were all marketed as medicine, whereas the
food teas showed an average composition.
Our results conﬁrm that it may be worthwhile to explore sage
as a food ingredient not only for its ﬂavor proﬁle but also for its
antioxidant capacity so that it may be a substitute for the synthetic
antioxidants that are commonly applied in foods (Madsen and
Bertelsen, 1995).
According to Wang et al. (1998), the compounds in sage with
the highest antioxidant capacity were found to be rosmarinic acid
and luteolin-7-O-β-glucopyranoside, of which rosmarinic acid
quantitatively dominated in our samples.
As mentioned in the introduction, there are no legal speci-
ﬁcations regarding these compounds in sage tea, which may be
an explanation for the obvious lack of quality awareness in this
regard. From a consumer’s perspective, it is surely a mandatory
demand that medicines contain the active principles in a deﬁned
amount. In the case of sage (as for many other traditional herbal
medicines), the active principle is not known. However, at least the
main components that have a hypothesized effect, such as polyphe-
nols or antioxidants, should be regulated. In their Salvia ofﬁcinalis
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monograph, the EMA – the regulatory authority in Europe – jus-
tiﬁed an acceptable daily intake (ADI) of thujone at 5.0 mg/person
for a maximum duration of use of 2 weeks (European Medicines
Agency, 2009). Lately, the EMA has reconsidered this ADI in a
public statement (European Medicines Agency, 2011). Nonethe-
less, if the regulatory authority holds the opinion that a certain
risk seems to be involved in the usage of sage as medicine, it is
difﬁcult to understand why minimum requirements of the pos-
sibly beneﬁciary compounds, have not yet been established. In
times when the public is discussing the ﬁnancing of healthcare
and the quality and the beneﬁts of medicines have to be evaluated,
it seems important for the credibility of herbal medicines to estab-
lish speciﬁcations. Therefore, a dose–beneﬁt assessment appears to
be necessary, which could be followed by minimum requirements
of the active principles. The FC index appears to be useful as a
screening parameter for sage tea quality, as it is highly correlated
with rosmarinic acid and easier to determine with less instrumen-
tal effort than the ORAC value or the speciﬁc compounds using
HPLC.
CONCLUSION
Currently, no standardization or quality control of polypheno-
lic compounds or antioxidant potential, which may be associated
with the beneﬁcial effects of sage, are conducted. In addition the
commercially available products are of highly variable compo-
sition. The plant material used in previous in vitro or in vivo
studies was in most cases not characterized in this regard (e.g.,
regarding content of rosmarinic acid or antioxidant potential):
therefore the transferability of study results to commercial mater-
ial per se remains questionable. Nevertheless, the limited available
in vivo evidence suggests that sage tea drinking may improve
lipid proﬁle and antioxidant defenses in humans (Sá et al., 2009).
Further research appears to be necessary to better characterize
the dose–beneﬁt relationship and to postulate minimum qual-
ity standards for medicinal sage tea that would guarantee the
ingestion of effective dosages. The commercial quality could
be improved by introducing minimum requirements into the
European Pharmacopoeia (2008) monograph or the ISO 11165
standard.
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